Abstract
An internal fragment of the cfb gene from group B streptococcal (GBS) strain R268 was amplified by polymerase chain reaction (PCR) using degenerate primers with sequences derived from the CAMP-factor amino acid (aa) sequence of GBS strain NCTC8181 [Rühlmann et al. (1988) FEBS Lett 235: 262–266]. After cloning and sequencing this fragment, the remainder of cfb and the adjacent 5′ and 3′ sequences were amplified by inverted PCR of genomic DNA and directly sequenced from the PCR product. Within the 1560 bp sequenced, a complete cfb gene deviating in two deduced aa residues from the published sequence was identified. In addition, the cfbR268 sequence contained a 29-aa leader peptide. Using primers directed to the 5′ and 3′ ends of cfb for PCR, a cfb gene of uniform size could be detected in 19 clinical GBS isolates including three phenotypically CAMP-negative strains. Utilizing Northern blot analysis and primer extension assays, the cfbR268 promoter was located and the length of the cfb transcript was assessed at about 1100 bp. In a parallel experiment, no cfb transcript could be detected from the CAMP-negative GBS strain 74–360. The complete cfbR268 gene and different portions of its 5′ and 3′ ends were cloned into the plasmid pJLA602 and expressed in E. coli DH5α. The recombinant peptides could be detected by Western immunoblots with polyclonal antiserum. Only the full-sized recombinant CAMP-factor was found to exert co-hemolytic activity in a sheep-blood agar assay. This co-hemolytic activity could be inhibited by anti-CAMP antiserum.
Similar content being viewed by others
References
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1990) Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York
Bernheimer AW, Linder R, Avigad LS (1979) Nature and mechanism of action of the CAMP protein of group B streptococci. Infect Immun 23:838–844
Chomczynski P (1992) Solubilization in formamide protects RNA from degradation. Nucleic Acids Res 20:3791–3792
Christie R, Atkins NE, Munch-Petersen E (1944) A note on a lytic phenomenon shown by group B streptococci. Aust J Exp Biol 22:197–200
Conrads G, Podbielski A, Lütticken R (1991) Molecular cloning and nucleotide sequence of the group B streptococcal hemolysin. Zentralbl Bakt 275:179–184
D'Aubenton Carafa Y, Brody E, Thermers C (1990) Prediction of rho-independent Escherichia coli transcription terminators. J Mol Biol 216:835–858
Edwards MS, Wessels MR, Baker CJ (1993) Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. Infect Immun 61:2866–2871
Erlich HA, Gelfand D, Sninsky JJ (1991) Recent advances in the polymerase chain reaction. Science 252:1643–1651.
Fehrenbach FJ, Jürgens D, Rühlmann J, Sterzik B, Özel M (1988) Role of CAMP-factor (protein B) for virulence. Zentralbl Bakt Hyg [Suppl] 17:351–357
Figura N, Guglielmetti P (1987) Differentiation of mobile and mesophilic Aeromonas strains into species by testing for a CAMP-like factor. J Clin Microbiol 25:1341–1342
Fraser G (1961) Hemolytic activity of Corynebacterium ovis. Nature 189:246
Fraser G (1962) The hemolysis of animal erythrocytes by Pasteurella haemolytica produced in conjunction with certain staphylococcal toxins. Res Vet Sci 3:104–110
Frey J, Perrin J, Nicolet J (1989) Cloning and expression of a cohemolysin, the CAMP factor of Actinobacillus pleuropneumoniae. Infect Immun 57:2050–2056
Heden LO, Frithz E, Lindahl G (1991) Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur J Immunol 21:1481–1490
Heeschen W, Tolle A, Zeidler H (1967) Zur Klassifizierung der Gattung Streptococcus. Zentralbl Bakt Mikrobiol Hyg [A] 205:250–259
Hulse ML, Smith S, Chi EY, Pham A, Rubens CR (1993) Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun 61:4835–4841
Huser H, Goeke L, Karst G, Fehrenbach FJ (1983) Fermenter growth of Streptococcus agalactiae and large scale production of CAMP-factor. J Gen Microbiol 129:1295–1300
Icho T, Bulawa CE, Raetz CRH (1985) Molecular cloning and sequencing of the gene for CDP-diglyceride hydrolase of Escherichia coli. J Biol Chem 260:12092–12098
Jürgens D, Shalaby FYYI, Fehrenbach FJ (1985) Purification and characterization of CAMPfactor from Streptococcus agalactiae by hydrophobic interaction chromatography and chromatofocussing. J Chromatogr 348:363–370
Jürgens D, Sterzik B, Fehrenbach FJ (1987) Unspecific binding of group B streptococcal cocytolysin (CAMP-factor) to immunoglobulins and its possible role in pathogenicity. J Exp Med 165:720–732
Killian M (1976) The hemolytic activity of Haemophilus species. Acta Pathol Microbiol Immunol Scand [B] 84:339–341
Köhler W (1988) CAMP-like phenomena of Vibrios. Zentralbl Bakt Hyg [A] 270:35–40
Lämmler C, Gütürk K, Blobel H (1987) CAMP-like reactions of group G streptococci from dogs. Med Sci Res 15:217–218
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Marques MB, Kasper DL, Pangburn MK, Wessels MR (1992) Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun 60:3986–3993
Martin NJ, Kaplan EL, Gerber MA, Menegus MA, Randolph M, Bell K, Cleary PP (1990) Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol 28:1881–1886
Michel JL, Madoff LC, Olson K, Kling DE, Kasper DL, Ausubel FM (1992) Large, identical, tandem repeating units in the C protein alpha antigen, bca, of group B streptococci. Proc Natl Acad Sci USA 89:10060–10064
Ochman H, Gerber AS, Hartl DL (1988) Genetic applications of an inverse polymerase chain reaction. Genetics 120:621–623
Pincus SH, Cole RL, Kamanga-Sollo E, Fischer SH (1993) Interaction of group B streptococcal opacity variants with the host defense system. Infect Immun 61:3761–3768
Podbielski A, Kühnemund O, Lütticken R (1990) Identification of group A type 1 streptococcal M protein gene by a non-radioactive oligonucleotide detection method. Med Microboil Immunol 179:255–262
Podbielski A, Schönling J, Melzer B, Haase G (1991) Different promoters of SHV-2 and SHV-2a β-lactamase lead to diverse levels of cefotaxime resistance in their bacterial producers. J Gen Microbiol 137:1667–1675
Podbielski A, Peterson JA, Cleary P (1992) Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes. Mol Microbiol 6:2253–2265
Pritchard DG, Lin B (1993) Group B streptococcal neuraminidase is actually a hyaluronidase. Infect Immun 61:3234–3239
Rocourt J, Grimont PAD (1983) Listeria welshimeri sp. nov. and Listeria seeligeri sp. nov. Int J Syst Bacteriol 33:866–869
Rühlmann J, Jürgens D, Fehrenbach RJ (1988) Separation of large hydrophobic fragments of protein B (CAMP-factor). Zentralbl Bakt Hyg [Suppl] 17:63–64
Rühlmann J, Wittmann-Liebold B, Jürgens D, Fehrenbach FJ (1988) Complete amino acid sequence of protein B. FEES Lett 235:262–266
Rühlmann J, Kruft V, Wittmann-Liebold B, Fehrenbach FJ (1989) Sequence similarity between protein B and human apolipoprotein A-IV. FEBS Lett 249:151–154
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Schlievert PM, Gocke JE, Deringer JR (1993) Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin Infect Dis 17:26–31
Schneewind O, Friedrich KH, Lütticken R (1988) Cloning and expression of the CAMPfactor of group B streptococci in Escherichia coli. Infect Immun 56:2174–2179
Skalka B, Smola J (1981) Lethal effect of CAMP-factor and UBERIS-factor — a new finding about diffusible exosubstances of Streptococcus agalactiae and Streptococcus uberis. Zentralbl Bakt Mikrobiol Hyg [A] 249:190–194
Stalhammar-Carlemalm M, Stenberg L, Lindahl G (1993) Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 177:1593–1603
von Heijne G, Abrahmsen L (1989) Species-specific variation in signal peptide design. FEBS Lett 244:439–446
Wessels MR, Paoletti LC, Rodewald AK, Michon F, DiFabio J, Jennings HJ, Kasper DL (1993) Stimulation of protective antibodies against type I a and I b group B streptococci by a type I a polysaccharide tetanus toxoid conjugate vaccine. Infect Immun 61:4760–4766
Wibawan IWT, Lämmler C (1990) Properties of group B streptococci with surface antigens X and R. J Clin Microbiol 28:2834–2836
Wilkinson HW (1977) CAMP-disk test for presumptive identification of group B streptococci. J Clin Microbiol 6:42–45
Zhou CY, Yang Y, Jong AY (1990) Miniprep in ten minutes. BioTechniques 8:172–173
Bohnsack JF, Chang JK, Hill HR (1993) Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species. Infect Immun 61:1421–1426
Cleary PP, Handley J, Suvurov AN, Podbielski A, Ferrieri P (1992) Similarity between the group B and A streptococcal C5a peptidase genes Infect Immun 60:4239–4244
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Podbielski, A., Blankenstein, O. & Lütticken, R. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor. Med Microbiol Immunol 183, 239–256 (1994). https://doi.org/10.1007/BF00198458
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00198458